Page last updated: 2024-09-03

candoxatrilat and Cruveilhier-Baumgarten Syndrome

candoxatrilat has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

*Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aragno, M; Danni, O; Mastrocola, R; Mengozzi, G; Parola, M; Restivo, F; Rizzetto, M; Rosina, F; Sansoè, G; Smedile, A1

Other Studies

1 other study(ies) available for candoxatrilat and Cruveilhier-Baumgarten Syndrome

ArticleYear
Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Journal of hepatology, 2005, Volume: 43, Issue:5

    Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Carbon Tetrachloride; Cyclic GMP; Cyclohexanecarboxylic Acids; Cytokines; Endothelin-1; Humans; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Neprilysin; Portal Vein; Protease Inhibitors; Rats; Rats, Wistar; Vascular Resistance

2005